News Peg. Nirsevimab, Sanofi and AstraZeneca’s RSV shot for infants received unanimous backing from an advisory committee to the CDC on August 3. This comes almost two months after an FDA ...

RSV infections of the lungs and airways send up to 160,000 older adults to the hospital each year, at an annual cost of more than $1.3 billion, according to the Michigan Medicine report.

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

We may use terms like cold and the flu as if they are the same thing, but there are some key differences between them.

A Canadian study highlights the elevated risks of heart failure and arrhythmia in older adults hospitalized for RSV, even ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

RSV is a respiratory virus that infects the nose, throat and lungs. While people with larger airways and strong immune systems aren't as adversely affected by the infection, young children and ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...